Increased detection of interleukin-;5 in sputum by addition of protease inhibitors

Kelly M.M., Leigh R., Carruthers S., Horsewood P., Gleich G.J., Hargreave F.E., Cox G.

Source: Eur Respir J 2001; 18: 685-691
Journal Issue: October
Disease area: Airway diseases

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Kelly M.M., Leigh R., Carruthers S., Horsewood P., Gleich G.J., Hargreave F.E., Cox G.. Increased detection of interleukin-;5 in sputum by addition of protease inhibitors. Eur Respir J 2001; 18: 685-691

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
SerpinB1 in cystic fibrosis airway fluids: quantity, molecular form and mechanism of elastase inhibition
Source: Eur Respir J 2011; 37: 1083-1090
Year: 2011



Increased serum concentration of urinary trypsin inhibitor with asthma exacerbation
Source: Eur Respir J 2003; 22: 739-742
Year: 2003



A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection
Source: Lung Science Conference 2015
Year: 2015

LSC Abstract – A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015

Development of the first protease multiplex immunoassay for active neutrophilic serine protease biomarkers
Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases
Year: 2021


In vivo pharmacological profile of PKF242-484 and PKF241-466, novel dual inhibitors of TNF-α converting enzyme and matrix metalloproteinases, in models of airway inflammation
Source: Eur Respir J 2002; 20: Suppl. 38, 169s
Year: 2002

Inhibitors of PDE4 delay eosinophil apoptosis
Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population
Year: 2005


Role of secretory leukocyte protease inhibitor in the development of subclinical emphysema
Source: Eur Respir J 2002; 19: 1050-1057
Year: 2002



Lysosomal cysteine proteases in the lung: role in protein processing and immunoregulation
Source: Eur Respir J 2004; 23: 620-628
Year: 2004



The proteasome - an intracellular protease that is dysregulated in lung diseases
Source: International Congress 2018 – Proteases: at the cutting edge of lung disease
Year: 2018


Treatment with proteinase inhibitor, BbCI, modulates inflammatory response, mechanic alterations, and remodeling on elastase-induced emphysema in mice
Source: Annual Congress 2012 - The many roads to lung injury
Year: 2012

Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients
Source: Eur Respir J 2005; 25: 885-890
Year: 2005



Ambroxol suppresses influenza-virus proliferation in the mouse airway by increasing antiviral factor levels
Source: Eur Respir J 2002; 19: 952-958
Year: 2002



BmTI-A, a serine protease inhibitor, reduces the chronic allergic lung inflammation in a mice model
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015

Impact of SARS-CoV-2 heat inactivation on active protease biomarkers in sputum sol
Source: Virtual Congress 2021 – Back to infection basics
Year: 2021


A method to preserve sputum for delayed examination
Source: Eur Respir J 2003 Dec 01;22(6):996-1000
Year: 2003



Detection and inhibition of ENaC-activating proteases associated with airway dehydration in COPD
Source: International Congress 2017 – From the bench: therapeutic approaches in COPD and emphysema
Year: 2017

Plant proteinase inhibitor from crataeva tapia (CrataBl) attenuates inflammation and remodelling induced by elastase in mice
Source: Annual Congress 2013 –Novel mechanisms in lung injury
Year: 2013

RV568, a narrow-spectrum kinase inhibitor with p38 MAPK-a and -? selectivity, suppresses COPD inflammation
Source: Eur Respir J, 50 (4) 1700188; 10.1183/13993003.00188-2017
Year: 2017



Differences in serum levels of inflammatory markers, proteases and antiproteases in COPD patients with and without emphysema
Source: Eur Respir J 2007; 30: Suppl. 51, 142s
Year: 2007